Anemia of inflammation, hypoferremia, poor transferrin saturation, and high levels of serum ferritin, hepcidin, lipocalin-2, catalytic iron, and soluble transferrin receptor (in ICU patients) have all been iron-associated changes in COVID-19 from the beginning [87]. This evidence concerns the gene LCN2 and COVID-19.